Saar Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.68 Cr
- Revenue Growth %
- Net Worth 1994.91%
- Total Assets 524.22%
About Saar Biotech
Saar Biotech Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 May 2012 and has a history of 12 years and eight months. Its registered office is in Chandigarh, Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.68 Cr.
Radhe Goyal and Anil Kumar serve as directors at the Company.
Company Details
-
Location
Chandigarh, Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2012PTC033813
-
Company No.
033813
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 May 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Saar Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhe Goyal
|
Director | 22-May-2012 | Current |
|
Anil Kumar
|
Director | 22-May-2012 | Current |
Financial Performance of Saar Biotech.
Saar Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1994.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saar Biotech?
In 2023, Saar Biotech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Alvizia Healthcare Private LimitedRadhe Goyal is a mutual person
-
Vsaar Pharma Private LimitedRadhe Goyal is a mutual person
-
Benhadded Pharma Private Limited
Radhe Goyal is a mutual person
Charges (Loans)
₹56.78 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 5.00 Cr
- Hdfc Bank Limited : 0.68 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2023 | Hdfc Bank Limited | ₹2.49 M | Open |
| 21 Jun 2022 | Hdfc Bank Limited | ₹1.79 M | Open |
| 28 Apr 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 18 Jan 2022 | Axis Bank Limited | ₹5.00 Cr | Open |
How Many Employees Work at Saar Biotech?
Saar Biotech has a workforce of 114 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saar Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
